Osteoporosis / Thrombosis / Diabetes / Heart attack

Categories

All ArticlesAntioxidant properties / No toxicity / SafetyCancer / Transport / DeliveryLife extension / Rheumatoid arthritis / Air toxicity / Ischemia / AtherosclerosisOsteoporosis / Thrombosis / Diabetes / Heart attackParkinson and AlzheimerVarious positive properties

Modulated podosome patterning in osteoclasts by fullerenol nanoparticles disturbs the bone resorption for osteoporosis treatment >>

Intrinsic Biotaxi Solution Based on Blood Cell Membrane Cloaking Enables Fullerenol Thrombolysis In Vivo >>

Influence of fullerenol on hIAPP aggregation: amyloid inhibition and mechanistic aspects >>

Interaction Principle Between Coagulation Factor X and Fullerene Derivatives with Different Hydrophilic-Hydrophobic Properties for Anticoagulation >>

Small size fullerenol nanoparticles inhibit thrombosis and blood coagulation through inhibiting activities of thrombin and FXa >>

Highly Dispersed Fullerenols Hamper Osteoclast Ruffled Border Formation by Perturbing Ca 2+ Bundles Osteoporosis, a common and serious bone disorder affecting aged people and postmenopausal women, is characterized by osteoclast overactivity. One therapeu >>

Fullerenol nanoparticles suppress RANKL-induced osteoclastogenesis by inhibiting differentiation and maturation >>

Axisymmetric Contact Problem for a Flattened Cell: Contributions of Substrate Effect and Cell Thickness to the Determination of Viscoelastic Properties by Using AFM Indentation >>

Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats >>

Back to top